Page last updated: 2024-08-16

salmeterol xinafoate and Hyperventilation

salmeterol xinafoate has been researched along with Hyperventilation in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	3 (60.00)	18.2507
2000's	2 (40.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aguilaniu, B	1
Eguchi, Y; Fujimoto, S; Hirata, K; Kamoi, H; Kanazawa, H; Kudoh, S; Tateishi, Y; Umeda, N; Yoshikawa, T	1
Cartier, A; Ghezzo, H; L'Archevêque, J; Malo, JL; Trudeau, C	2
Jörres, R; Lüthke, M; Magnussen, H; Nowak, D; Rabe, KF; Wiessmann, J	1

Trials

4 trial(s) available for salmeterol xinafoate and Hyperventilation

Article	Year
Effects of tiotropium or combined therapy with salmeterol on hyperinflation in COPD. Osaka city medical journal, 2007, Volume: 53, Issue:1 Topics: Aged; Albuterol; Bronchodilator Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Forced Expiratory Volume; Humans; Hyperventilation; Inspiratory Capacity; Lung; Lung Volume Measurements; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive; Quality of Life; Respiratory Function Tests; Salmeterol Xinafoate; Scopolamine Derivatives; Tiotropium Bromide	2007
Salmeterol, a new inhaled beta 2-adrenergic agonist, has a longer blocking effect than albuterol on hyperventilation-induced bronchoconstriction. The Journal of allergy and clinical immunology, 1992, Volume: 89, Issue:2 Topics: Adolescent; Adrenergic beta-Agonists; Adult; Albuterol; Asthma; Bronchoconstriction; Cold Temperature; Double-Blind Method; Female; Humans; Hyperventilation; Male; Middle Aged; Respiratory Function Tests; Salmeterol Xinafoate; Time Factors	1992
[Duration of bronchial protective effect of salmeterol in asthma induced by hyperventilation with dry cold air]. Revue des maladies respiratoires, 1992, Volume: 9 Suppl 1 Topics: Adrenergic beta-Agonists; Adult; Albuterol; Asthma; Bronchial Provocation Tests; Bronchoconstriction; Double-Blind Method; Female; Humans; Hyperventilation; Male; Salmeterol Xinafoate	1992
Salmeterol protects against hyperventilation-induced bronchoconstriction over 12 hours. European journal of clinical pharmacology, 1992, Volume: 43, Issue:6 Topics: Adult; Albuterol; Asthma; Bronchial Provocation Tests; Bronchoconstriction; Bronchodilator Agents; Double-Blind Method; Female; Humans; Hyperventilation; Male; Salmeterol Xinafoate	1992

Other Studies

1 other study(ies) available for salmeterol xinafoate and Hyperventilation

Article	Year
[Efficacy of bronchodilators: searching for objective criteria]. Revue de pneumologie clinique, 2003, Volume: 59, Issue:2 Pt 2 Topics: Administration, Inhalation; Adrenergic beta-Agonists; Albuterol; Bronchodilator Agents; Dyspnea; Exercise; Follow-Up Studies; Functional Residual Capacity; Humans; Hyperventilation; Placebos; Plethysmography; Pulmonary Disease, Chronic Obstructive; Quality of Life; Respiratory Function Tests; Salmeterol Xinafoate; Spirometry; Time Factors; Total Lung Capacity	2003

Article

Year

[Efficacy of bronchodilators: searching for objective criteria].

Revue de pneumologie clinique, 2003, Volume: 59, Issue:2 Pt 2

Topics: Administration, Inhalation; Adrenergic beta-Agonists; Albuterol; Bronchodilator Agents; Dyspnea; Exercise; Follow-Up Studies; Functional Residual Capacity; Humans; Hyperventilation; Placebos; Plethysmography; Pulmonary Disease, Chronic Obstructive; Quality of Life; Respiratory Function Tests; Salmeterol Xinafoate; Spirometry; Time Factors; Total Lung Capacity

2003